Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Serge Gauthier

Serge Gauthier

individual
Ecosystem influencer

About

Serge Gauthier is a Canadian neurologist and academic specializing in Alzheimer's disease, dementia, and neurodegenerative disorders. Public sources identify him as a Full Professor at McGill University and director of the Alzheimer Disease and Related Disorders Research Unit at the Douglas Research Centre/McGill Center for Studies in Aging. He also serves in advisory roles to neurodegeneration-focused companies including Perceiv AI, ADvantage Therapeutics, and Mediti Pharma.

Areas of interest

alzheimers diseasedementianeurodegenerationclinical trialsbiotech therapeuticsaginglongevity